These findings raise the intriguing possibility that targeting PHGDH in macrophages could serve as a promising therapeutic approach for solid tumors, particularly in younger individuals with low or negligible PHGDH expression in tumor cells. The gene discussed is PHGDH; the disease is neoplasm.